Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Recruiting

Phase 1

Phase 2

AbemaciclibAbemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Sponsor:

National Cancer Institute (NCI)

Code:

NCT04941274

Conditions

Kaposi Sarcoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abemaciclib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-24. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-03-13.